Prospects of Disease-Modifying Osteoarthritis Drugs

被引:4
作者
Oo, Win Min [1 ,2 ]
机构
[1] Univ Med, Mandalay Gen Hosp, Dept Phys Med & Rehabil, Mandalay, Mandalay, Myanmar
[2] Univ Sydney, Royal North Shore Hosp, Inst Bone & Joint Res, Kolling Inst,Rheumatol Dept, Sydney, Australia
关键词
Osteoarthritis; DMOADs; Disease-modifying drugs; Intra-articular therapy; endotype; BONE-MARROW LESIONS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; REDUCES CARTILAGE LOSS; POST-HOC ANALYSIS; GROWTH-FACTOR; 18; KNEE OSTEOARTHRITIS; INTRAARTICULAR SPRIFERMIN; CATHEPSIN K; SUBCHONDRAL BONE; CLINICAL-TRIALS;
D O I
10.1016/j.rdc.2024.03.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:483 / 518
页数:36
相关论文
共 141 条
  • [11] Effect of Intravenous Zoledronic Acid on Tibiofemoral Cartilage Volume Among Patients With Knee Osteoarthritis With Bone Marrow Lesions A Randomized Clinical Trial
    Cai, Guoqi
    Aitken, Dawn
    Laslett, Laura L.
    Pelletier, Jean-Pierre
    Martel-Pelletier, Johanne
    Hill, Catherine
    March, Lyn
    Wluka, Anita E.
    Wang, Yuanyuan
    Antony, Benny
    Blizzard, Leigh
    Winzenberg, Tania
    Cicuttini, Flavia
    Jones, Graeme
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (15): : 1456 - 1466
  • [12] Unmet Needs in the Osteoarthritis Chronic Moderate to Severe Pain Management in Spain: A Real Word Data Study
    Castro-Dominguez, Francisco
    Vargas-Negrin, Francisco
    Perez, Concepcion
    Gutierrez-Prieto, Hector
    Rebollo, Pablo
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (03) : 1113 - 1127
  • [13] Parathyroid hormone-(1-34) ameliorated knee osteoarthritis in rats via autophagy
    Chen, Chung-Hwan
    Ho, Mei-Ling
    Chang, Ling-Hua
    Kang, Lin
    Lin, Yi-Shan
    Lin, Sung-Yen
    Wu, Shun-Cheng
    Chang, Je-Ken
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2018, 124 (05) : 1177 - 1185
  • [14] Promising targets for therapy of osteoarthritis: a review on the Wnt and TGF-β signalling pathways
    Cherifi, Chahrazad
    Monteagudo, Silvia
    Lories, Rik J.
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [15] Cho J, 2017, CYTOTHERAPY, V19, pS90
  • [16] Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection
    Cikach, Frank S.
    Koch, Christopher D.
    Mead, Timothy J.
    Galatioto, Josephine
    Willard, Belinda B.
    Emerton, Kelly B.
    Eagleton, Matthew J.
    Blackstone, Eugene H.
    Ramirez, Francesco
    Roselli, Eric E.
    Apte, Suneel S.
    [J]. JCI INSIGHT, 2018, 3 (05):
  • [17] Semiquantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium
    Collins, Jamie E.
    Losina, Elena
    Nevitt, Michael C.
    Roemer, Frank W.
    Guermazi, Ali
    Lynch, John A.
    Katz, Jeffrey N.
    Kwoh, C. Kent
    Kraus, Virginia B.
    Hunter, David J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (10) : 2422 - 2431
  • [18] Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis A Randomized Controlled Trial
    Conaghan, Philip G.
    Bowes, Michael A.
    Kingsbury, Sarah R.
    Brett, Alan
    Guillard, Gwenael
    Rizoska, Biljana
    Sjogren, Niclas
    Graham, Philippa
    Jansson, Asa
    Wadell, Cecilia
    Bethell, Richard
    Ohd, John
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (02) : 86 - +
  • [19] Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
    Coppe, Jean-Philippe
    Patil, Christopher K.
    Rodier, Francis
    Sun, Yu
    Munoz, Denise P.
    Goldstein, Joshua
    Nelson, Peter S.
    Desprez, Pierre-Yves
    Campisi, Judith
    [J]. PLOS BIOLOGY, 2008, 6 (12) : 2853 - 2868
  • [20] Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis
    Costa, Aline G.
    Cusano, Natalie E.
    Silva, Barbara C.
    Cremers, Serge
    Bilezikian, John P.
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (08) : 447 - 456